Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
J Vet Cardiol ; 41: 154-164, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35364502

ABSTRACT

INTRODUCTION: Systemic administration of tissue plasminogen activator (tPA) is seldomly reported in dogs and cats. ANIMALS: Client-owned animals receiving tPA (2010-2020). MATERIALS AND METHODS: Medical records of dogs and cats receiving tPA for distant known/suspected thrombus were reviewed. Fourteen dog visits (24 injections) and five cat visits (six injections) were included. RESULTS: Canine known/suspected thrombus included pulmonary thromboembolism (n=6), intracardiac thrombus (n=4), aortic thrombus (n=1), cranial vena cava thrombus (n=2), and femoral and iliac veins thrombus (n=1). Various canine primary diseases were represented, but open-heart surgery was the most common cause. Median time between diagnosis/suspicion of thrombus and tPA injection was 24.5 h (range, 3-150 h). Mean total tPA dose was 1.0±0.78 mg/kg. Clinical improvement occurred in 93% of dogs. Non-fatal complications were reported in 14% of dogs. Dogs' survival to discharge was 78.6% without identifiable non-survivor characteristics. Feline known/suspected thrombus included unilateral feline aortic thromboembolism (FATE) (n=2), bilateral FATE (n=2), and right renal artery thrombus. Feline primary diseases included cardiomyopathy (n=5). Median time between diagnosis/suspicion of thrombus and tPA injection was 4 h (range, 2-17 h) and median total tPA dose was 1.0 mg/kg (range, 0.6-1.4 mg/kg).Clinical improvement occurred during 40% of the visits. All cats (n=3) with acute kidney injury (AKI) at admission developed worsening AKI and reperfusion injury. Of the remaining two visits, one developed a non-fatal AKI. Cats' survival to discharge was 40%. CONCLUSIONS: Systemic thrombolysis with tPA seems to be effective and safe in dogs. More investigation is needed in cats.


Subject(s)
Cat Diseases , Dog Diseases , Thrombolytic Therapy , Thrombosis , Tissue Plasminogen Activator , Animals , Cat Diseases/drug therapy , Cats , Dog Diseases/drug therapy , Dogs , Retrospective Studies , Thrombolytic Therapy/veterinary , Thrombosis/drug therapy , Thrombosis/veterinary , Tissue Plasminogen Activator/therapeutic use , Treatment Outcome
2.
J Vet Cardiol ; 41: 70-78, 2022 Jun.
Article in English | MEDLINE | ID: mdl-35248977

ABSTRACT

Trifoliate left atrioventricular (AV) valve with common atrioventricular junction is considered part of the spectrum of atrioventricular septal defect. This valve morphology is typically associated with defects in the AV septum resulting in communication at the atrial or ventricular level, but has also been described as an isolated defect in the setting of a common AV junction without AV septal defect. Trifoliate left AV valve exhibits a line of apposition between the bridging leaflets that is directed toward the inlet interventricular septum, distinguishing it from isolated mitral valve cleft in which the orientation of the bridging leaflets are toward the left ventricular outflow tract. The echocardiographic findings of four dogs with trifoliate left AV valve are described; two with intact septal structures and two with large ostium primum defects. Three dogs underwent open surgical repair using different approaches depending on the presence or absence of a septal defect. One of these underwent concurrent surgical repair for right AV valve dysplasia. One dog with intact septal structures underwent interventional closure of a concurrent patent ductus arteriosus. Current terminology associated with trileaflet left AV valve malformations is reviewed.


Subject(s)
Dog Diseases , Heart Septal Defects, Atrial , Heart Septal Defects, Ventricular , Heart Valve Diseases , Animals , Dog Diseases/diagnostic imaging , Dog Diseases/surgery , Dogs , Echocardiography/methods , Echocardiography/veterinary , Heart Septal Defects , Heart Septal Defects, Atrial/diagnostic imaging , Heart Septal Defects, Atrial/surgery , Heart Septal Defects, Atrial/veterinary , Heart Septal Defects, Ventricular/diagnostic imaging , Heart Septal Defects, Ventricular/surgery , Heart Septal Defects, Ventricular/veterinary , Heart Valve Diseases/veterinary , Mitral Valve/surgery
3.
J Vet Cardiol ; 36: 105-114, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34192609

ABSTRACT

INTRODUCTION: Combining an antiplatelet drug, clopidogrel, with the direct oral Factor Xa inhibitor, apixaban, could provide an effective antithrombotic strategy in dogs. Thus, a limited 3 + 3 phase I dose-escalation clinical trial in healthy dogs was conducted to evaluate bleeding (primary end-point) and pharmacodynamic (PD)/pharmacokinetic (PK) parameters (secondary end-point). ANIMALS: Eleven beagle dogs, median body weight 10.2 kg (9.7-10.9 kg), were enrolled. METHODS: Four doses of apixaban (three dogs/dose) administered for eight days. Clopidogrel dose was fixed at 18.75 mg per os (PO) q 24 h with escalation of apixaban dose at 5 mg PO q 12 h, 5 mg PO q 8 h, 10 mg PO q 12 h, and 10 mg PO q 8 h. Laboratory testing included fecal occult blood, coagulation parameters, Factor X activity, apixaban concentration, platelet aggregometry, and thromboelastography on days 1, 3, and 8. RESULTS: Evidence of bleeding was not observed at any dosage. Dose-dependent changes in PD/PK parameters between baseline and 3 h post-medication were observed including a prolongation of prothrombin time, a prolongation of activated partial thromboplastin time, a decrease of Factor X activity level, and increased apixaban concentration. CONCLUSIONS: The combination of apixaban at a dosage range of approximately 0.5 mg/kg PO q 12 h to 1 mg/kg PO q 8 h and clopidogrel at approximately 1.8 mg/kg PO q 24 h did not cause bleeding over a one-week period in healthy dogs. Clinically relevant changes in PD/PK data occur at all dosage levels. This study provides a starting point for longer-term clinical trials to determine safety and efficacy.


Subject(s)
Pyrazoles/therapeutic use , Pyridones/therapeutic use , Animals , Clinical Trials, Phase I as Topic , Clopidogrel , Dogs , Fibrinolytic Agents , Pharmaceutical Preparations
4.
J Vet Cardiol ; 25: 32-40, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31542555

ABSTRACT

Pulmonary artery banding (PAB) is a viable but underreported palliative option for hemodynamically significant ventricular septal defect in small animals. A significant challenge associated with PAB is judging the degree of band tightening, which can be further complicated when animals are immature and still growing at the time of PAB. If a pulmonary artery band is overtightened or becomes progressively too tight after surgery, the result can be reversal of shunt flow with potentially devastating consequences. Placement of a band that could be percutaneously dilated using a balloon catheter affords a minimally invasive option for partially or completely relieving the band should it become too tight after PAB. This report describes a surgical technique for placement of a dilatable pulmonary artery band, reviews guidelines for tightening the band, and reports the outcome of three cats undergoing the procedure. All three cats showed evidence of reduced hemodynamic load after PAB for a period of up to three years after PAB.


Subject(s)
Cat Diseases/surgery , Heart Septal Defects, Ventricular/veterinary , Pulmonary Artery/surgery , Animals , Cats , Heart Septal Defects, Ventricular/surgery , Hemodynamics , Male , Surgical Equipment , Thoracotomy/veterinary
5.
J Am Vet Med Assoc ; 219(8): 1089-93, 1073, 2001 Oct 15.
Article in English | MEDLINE | ID: mdl-11700706

ABSTRACT

Tetralogy of Fallot is a congenital heart defect that causes cyanosis, severe progressive weakness and activity intolerance, polycythemia, and shortened life span in dogs. Open surgical repair of tetralogy of Fallot consisting of closure of the ventricular septal defect and reconstruction of the right ventricular outflow tract via a right ventriculotomy during cardiopulmonary bypass is feasible in severely affected dogs. Successful surgical repair can completely resolve clinical signs associated with the defect.


Subject(s)
Cardiopulmonary Bypass/veterinary , Dogs/abnormalities , Heart Septal Defects, Ventricular/veterinary , Tetralogy of Fallot/veterinary , Animals , Dogs/surgery , Female , Heart Septal Defects, Ventricular/surgery , Male , Tetralogy of Fallot/physiopathology , Tetralogy of Fallot/surgery , Treatment Outcome
6.
J Am Anim Hosp Assoc ; 36(2): 115-9, 2000.
Article in English | MEDLINE | ID: mdl-10730620

ABSTRACT

A two-year-old cat with episodic dyspnea was diagnosed with an intrapericardial cyst via two-dimensional echocardiography. The cyst directly compressed the right ventricle, resulting in cardiac tamponade. Centesis of the cyst was performed to reduce tamponade prior to surgery. At surgery, a large, fluid-filled cystic structure was found within the pericardium. The cystic structure was continuous with a pedicle of liver that passed through a small peritoneopericardial diaphragmatic hernia. Surgical resolution was achieved by median sternotomy, midline pericardotomy, resection of the cyst, and diaphragmatic herniorrhaphy.


Subject(s)
Cardiac Tamponade/veterinary , Cat Diseases/etiology , Mediastinal Cyst/veterinary , Animals , Cardiac Tamponade/etiology , Cat Diseases/diagnosis , Cat Diseases/surgery , Cats , Male , Mediastinal Cyst/complications , Mediastinal Cyst/diagnosis , Mediastinal Cyst/surgery
7.
J Am Vet Med Assoc ; 216(3): 364-7, 2000 Feb 01.
Article in English | MEDLINE | ID: mdl-10668534

ABSTRACT

OBJECTIVE: To compare outcome and intermediate-term survival for dogs undergoing open surgical correction of subvalvular aortic stenosis (SAS) with those for dogs with SAS that did not undergo surgery. DESIGN: Retrospective study. ANIMALS: 44 dogs with congenital SAS. PROCEDURE: Maximum instantaneous systolic pressure gradients were determined by use of Doppler echocardiography. Cardiopulmonary bypass and open surgical correction of SAS (membranectomy with or without septal myectomy) was performed in 22 dogs, whereas 22 dogs did not undergo surgical correction. Cumulative survival was compared between surgical and nonsurgical groups, using Kaplan-Meier nonparametric analysis and a Mantel-Cox log-rank test. RESULTS: Initial systolic pressure gradients were not significantly different for dogs undergoing surgery (128 +/- 55 mm Hg), compared with those that did not undergo surgery (117 +/- 57 mm Hg). Systolic pressure gradients were significantly decreased after surgery in dogs that underwent surgery (54 +/- 27 mm Hg). Cumulative survival was not significantly different between dogs in the surgical and nonsurgical groups. Censoring surgery-related mortality in the analysis still did not reveal a significant difference in cumulative survival between the surgical and nonsurgical groups. CONCLUSIONS AND CLINICAL RELEVANCE: Despite reductions in the systolic pressure gradient and possible associated improvement in exercise tolerance, a palliative benefit on survival was not documented in dogs undergoing surgery for SAS.


Subject(s)
Aortic Stenosis, Subvalvular/veterinary , Dog Diseases/mortality , Dog Diseases/surgery , Adrenergic beta-Antagonists/therapeutic use , Animals , Aortic Stenosis, Subvalvular/congenital , Aortic Stenosis, Subvalvular/mortality , Aortic Stenosis, Subvalvular/surgery , Atenolol/therapeutic use , Blood Pressure , Cardiopulmonary Bypass/veterinary , Dog Diseases/congenital , Dogs , Echocardiography, Doppler/veterinary , Heart Septum/surgery , Retrospective Studies , Survival Analysis , Treatment Outcome
8.
Pacing Clin Electrophysiol ; 22(11): 1625-33, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10598966

ABSTRACT

Skeletal muscle deterioration is emerging as a limitation to long-term cardiac assist by dynamic cardiomyoplasty. Chronic electrical stimulation of in situ skeletal muscle showed that ischemia, decreased muscle preload, muscle overuse, and chronic electrical stimulation are factors for muscle deterioration. Transposition around the heart has been associated with signs of muscle denervation after chronic electrical stimulation. To evaluate latissimus dorsi muscle neuromuscular function after longterm dynamic cardiomyoplasty, we performed neuromuscular functional analysis and histology on the latissimus dorsi muscle and thoracodorsal nerve of six normal goats and six goats after 6 months of dynamic cardiomyoplasty. Electromyographic analysis showed positive sharp waves and fibrillation potentials in the latissimus dorsi of three goats from the dynamic cardiomyoplasty group. Conduction velocity of the thoracodorsal nerve of goats from the dynamic cardiomyoplasty group (58.32+/-9.80 m/s) was reduced compared to the goats from the control group (71.48+/-5.71 m/s, P = 0.02). Histologic changes in skeletal muscle were compatible with denervation. Loss of myelin sheaths, collapse of endoneurial connective tissue, and solitary foci of axonophagia and myelinophagia further documented severe injury to the thoracodorsal nerve in goats from the dynamic cardiomyoplasty group. The latissimus dorsi muscle wrap was denervated after long-term dynamic cardiomyoplasty. Traction on the neurovascular pedicle at each contraction of the transposed muscle may induce afferent axonal injury of the thoracodorsal nerve resulting in diminished muscular function.


Subject(s)
Cardiomyoplasty , Electromyography , Neuromuscular Junction/physiopathology , Animals , Goats , Muscle Denervation , Muscle, Skeletal/pathology , Muscle, Skeletal/physiopathology , Myocardial Contraction/physiology , Neuromuscular Junction/pathology
9.
J Card Fail ; 5(3): 255-64, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10496198

ABSTRACT

BACKGROUND: To eliminate the noncardiac toxicities associated with Adriamycin (Pharmacia Upjohn, Kalamazoo, MI) and to avoid the need for surgical implantation of a coronary artery catheter, we proposed serial intracoronary infusions of Adriamycin (Pharmacia Upjohn) with a Judkins catheter to develop a nonsurgical but selective model of dilated cardiomyopathy in dogs. METHODS AND RESULTS: Twenty-two dogs were entered onto the study. Each dog received four weekly injections of Adriamycin (Pharmacia Upjohn; 15 mg/wk) through a Judkins catheter and verapamil orally (5 mg/kg twice daily) for 4 weeks. Dogs were evaluated with echocardiography, right-sided cardiac catheterization, and endomyocardial biopsy at times 0 and 10 weeks. The left ventricular ejection fraction decreased from 0.65 +/- 0.04 to 0.48 +/- 0.11 (P = .0006). The left ventricular end-diastolic and end-systolic diameter indices increased from 42.00 +/- 2.17 to 46.92 +/- 5.81 mm (P = .0029) and from 27.65 +/- 2.59 to 35.00 +/- 6.84 mm, respectively (P = .0210). The mechanical cardiac efficiency decreased from 28.55% +/- 13.30% at baseline and 15.64% +/- 9.09% at 10 weeks (P = .001). Cardiac myocyte vacuolation was present on histological examination at 10 weeks. The mortality rate was 41%. Minimal systemic Adriamycin (Pharmacia Upjohn) toxicity was noticed. CONCLUSION: Intracoronary injection of Adriamycin (Pharmacia Upjohn) in dogs induced a chronic dilated cardiomyopathy.


Subject(s)
Doxorubicin/toxicity , Heart Failure/chemically induced , Heart Rate , Heart Ventricles/physiopathology , Stroke Volume , Animals , Biopsy , Cardiac Catheterization , Coronary Vessels , Disease Models, Animal , Dogs , Doxorubicin/administration & dosage , Echocardiography , Heart Failure/pathology , Heart Failure/physiopathology , Heart Rate/drug effects , Heart Ventricles/diagnostic imaging , Heart Ventricles/pathology , Injections, Intra-Arterial , Stroke Volume/drug effects
10.
J Vet Intern Med ; 13(5): 440-7, 1999.
Article in English | MEDLINE | ID: mdl-10499728

ABSTRACT

Pulmonary hypertension occurs as a primary or secondary disorder of the pulmonary vasculature. Doppler echocardiography provides a noninvasive tool for the estimation of pulmonary arterial pressure when tricuspid regurgitation or pulmonic insufficiency is present. The cardiology database at Colorado State University was reviewed, and echocardiographic records from cases diagnosed with pulmonary hypertension were evaluated. Application of the modified Bernoulli equation to the maximal instantaneous velocity of a right-sided regurgitant jet provided evidence of pulmonary hypertension in 53 dogs over a 4-year period. Tricuspid regurgitant velocity > or = 2.8 m/second or pulmonic insufficiency velocity > or = 2.2 m/second was considered abnormal and indicative of pulmonary hypertension. Tricuspid regurgitant gradients in 51 dogs ranged from 32 to 145 mm Hg (mean, 63.0 mm Hg; median, 57.0 mm Hg; 25th-75th percentiles, 45.2-76.5 mm Hg). Pulmonic insufficiency gradients in 8 dogs ranged from 20 to 100 mm Hg (mean, 59.5 mm Hg; median, 61.5 mm Hg; 25th-75th percentiles, 32.0-84.5 mm Hg). Affected dogs ranged in age from 2 months to 16 years. Clinical signs were characteristic of cardiopulmonary disease, but a relatively high frequency of syncope was noted (12 of 53 dogs, 23%). Pulmonary hypertension was probably due to increased pulmonary vascular resistance in 23 dogs, pulmonary overcirculation in 2 dogs, and pulmonary venous hypertension in 23 dogs. Five dogs lacked a clinically recognizable cardiopulmonary cause of pulmonary vascular disease. Our results suggest that pulmonary hypertension can occur as a complication of commonly encountered cardiopulmonary diseases, and that Doppler echocardiography can facilitate recognition of this condition.


Subject(s)
Dog Diseases/diagnostic imaging , Echocardiography, Doppler/veterinary , Hypertension, Pulmonary/veterinary , Animals , Binomial Distribution , Diagnosis, Differential , Dogs , Echocardiography, Doppler/standards , Female , Hypertension, Pulmonary/diagnostic imaging , Male , Medical Records , Predictive Value of Tests , Retrospective Studies
11.
Pacing Clin Electrophysiol ; 21(9): 1741-6, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9744437

ABSTRACT

Optimization of the skeletal muscle contraction during cardiac assist is important to achieve maximal cardiac assist and yet avoid overstimulation that may injure skeletal muscle. Dynamic cardiomyoplasty suffers from lack of an objective, reproducible, and accurate technique to measure skeletal muscle shortening fraction after wrap and training of the muscle. A recruitment curve is considered the best way to select the proper stimulation level to achieve supramaximal contraction without overstimulating the muscle. A fluoroscopic technique of determining latissimus dorsi recruitment curve was evaluated in five goats undergoing dynamic cardiomyoplasty with an anterior cardio-subcutaneous wrap. Two pairs of stainless steel targets (0.5 and 1 cm of diameter) were implanted on each side of the muscle wrap. One pair of sonomicrometer crystals was also implanted. Displacement of the targets was measured under fluoroscopy at five different stimulation levels. Correlation coefficients between targets on the inside surface of the wrap and the sonomicrometer crystals, and targets on the outside surface of the wrap and the sonomicrometer crystals were 0.71 (P < 0.05) and 0.60 (P < 0.05), respectively. Targets on the inside surface of the wrap were more accurate than targets on the outside surface of the wrap for measurement of skeletal muscle shortening fraction and establishment of a recruitment curve. Adverse effects from the targets were not observed.


Subject(s)
Cardiomyoplasty , Fluoroscopy/instrumentation , Myocardial Contraction/physiology , Postoperative Complications/physiopathology , Animals , Goats , Hemodynamics/physiology , Prostheses and Implants , Sensitivity and Specificity
12.
J Zoo Wildl Med ; 29(2): 225-7, 1998 Jun.
Article in English | MEDLINE | ID: mdl-9732042

ABSTRACT

Two half-sibling neonatal llamas (Lama glama) and one unrelated adult llama were presented with various complaints, including failure to thrive, respiratory distress, and excessive recumbency. The related camelids were born in successive years to the same dam but from unrelated sires. Thoracic auscultation revealed significant systolic and diastolic murmurs on both sides of the chest in all three llamas, and arterial blood gas evaluation revealed hypoxemia in two llamas. Echocardiographic examinations revealed large atrioventricular septal (AVS) defects in all three llamas. Two llamas were euthanized after diagnosis and the third died 4 mo later. Postmortem examination confirmed large AVS defects in all animals. There also was marked cardiomegaly in each animal. The discovery of such a cardiac anomaly in these three camelids suggests that it may be common in this species and may have a genetic basis.


Subject(s)
Camelids, New World/abnormalities , Heart Septal Defects/veterinary , Animals , Echocardiography, Doppler, Color/veterinary , Female , Heart Auscultation/veterinary , Heart Septal Defects/diagnosis , Heart Septal Defects/genetics , Male
13.
Am J Physiol ; 275(3): L593-600, 1998 09.
Article in English | MEDLINE | ID: mdl-9728055

ABSTRACT

Tremendous changes in pressure and flow occur in the pulmonary and systemic circulations after birth, and these hemodynamic changes should markedly affect endothelial cell replication. However, in vivo endothelial replication rates in the neonatal period have not been reported. To label replicating endothelial cells, we administered the thymidine analog bromodeoxyuridine to calves approximately 1, 4, 7, 10, and 14 days old before they were killed. Because we expected the ratio of replicating to nonreplicating cells to vary with vascular segment, we examined the main pulmonary artery, a large elastic artery, three sizes of intrapulmonary arteries, the aorta, and the carotid artery. In normoxia for arteries < 1,500 micron, approximately 27% of the endothelial cells were labeled on day 1 but only approximately 2% on day 14. In the main pulmonary artery, only approximately 4% of the endothelial cells were labeled on day 1 and approximately 2% on day 14. In contrast, in the aorta, approximately 12% of the endothelial cells were labeled on day 1 and approximately 2% on day 14. In chronically hypoxic animals, only approximately 14% of the endothelial cells were labeled on day 1 in small lung arteries and approximately 8% were still labeled on day 14. We conclude that the postnatal circulatory adaptation to extrauterine life includes significant changes in endothelial cell proliferation that vary dramatically with time and vascular location and that these changes are altered in chronic hypoxia.


Subject(s)
Endothelium, Vascular/cytology , Hemodynamics , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/physiopathology , Pulmonary Artery/pathology , Pulmonary Artery/physiopathology , Animals , Animals, Newborn , Carbon Dioxide/blood , Cattle , Cell Division , Cell Nucleus/pathology , Cell Nucleus/ultrastructure , Endothelium, Vascular/pathology , Endothelium, Vascular/physiology , Endothelium, Vascular/physiopathology , Hypertension, Pulmonary/blood , Hypoxia , Male , Models, Cardiovascular , Oxygen/blood , Partial Pressure , Pulmonary Artery/cytology , Pulmonary Artery/physiology , Time Factors
14.
J Am Anim Hosp Assoc ; 34(5): 383-6, 1998.
Article in English | MEDLINE | ID: mdl-9728468

ABSTRACT

A seven-month-old, male domestic shorthair was presented for respiratory distress. Cor triatriatum sinister was diagnosed based on echocardiography. Surgical dilatation and tearing of the anomalous membrane dividing the left atrium resulted in resolution of clinical signs. Intraoperative echocardiography was used to evaluate the adequacy of the repair.


Subject(s)
Cat Diseases/surgery , Cats/abnormalities , Cor Triatriatum/veterinary , Animals , Cat Diseases/diagnostic imaging , Cats/surgery , Cor Triatriatum/diagnostic imaging , Cor Triatriatum/surgery , Echocardiography, Doppler/veterinary , Echocardiography, Doppler, Color/veterinary , Male
15.
J Am Vet Med Assoc ; 212(8): 1276-80, 1998 Apr 15.
Article in English | MEDLINE | ID: mdl-9569169

ABSTRACT

OBJECTIVE: To determine factors associated with disease-free interval and survival time for dogs with pericardial effusion. DESIGN: Retrospective study. ANIMALS: 46 dogs. PROCEDURE: Signalment, history, results of physical examination, electrocardiography, echocardiography, and thoracic radiography; disease-free interval; and survival time were obtained from medical records or telephone conversations with owners and referring veterinarians. RESULTS: Dogs that had ascites at the time of the initial physical examination were significantly less likely, and dogs that had evidence of pulmonary metastases on thoracic radiographs or that had echocardiographic evidence of a right atrial mass were significantly more likely, to have died of pericardial effusion or the underlying cause of effusion than were dogs that did not. Median survival time was 15.3 months for dogs with idiopathic pericardial effusion, 16 days for dogs with hemangiosarcoma, and 13.6 months for dogs with mesothelioma. Dogs that had a nonspecific extracardiac mass and underwent pericardiectomy were significantly less likely to have had recurrence of signs than were dogs that did not. However, dogs with mesothelioma or hemangiosarcoma that underwent pericardiectomy did not have a significantly different risk of recurrence of signs or survival time, compared with dogs that did not. CLINICAL IMPLICATIONS: Results suggest that pericardiectomy will not affect risk of recurrence or survival time in dogs with pericardial effusion secondary to hemangiosarcoma or mesothelioma. However, pericardiectomy is still needed to differentiate dogs with neoplastic pericardial effusion from dogs with idiopathic pericardial effusion.


Subject(s)
Dog Diseases/mortality , Pericardial Effusion/veterinary , Animals , Ascites/complications , Ascites/veterinary , Disease-Free Survival , Dog Diseases/diagnosis , Dog Diseases/etiology , Dogs , Echocardiography/veterinary , Female , Heart Neoplasms/complications , Heart Neoplasms/veterinary , Hemangiosarcoma/complications , Hemangiosarcoma/secondary , Hemangiosarcoma/veterinary , Lung Neoplasms/secondary , Male , Mesothelioma/complications , Mesothelioma/veterinary , Pericardial Effusion/diagnosis , Pericardial Effusion/mortality , Pericardiectomy/veterinary , Prognosis , Proportional Hazards Models , Radiography, Thoracic/veterinary , Retrospective Studies , Risk Factors , Time Factors
16.
J Card Surg ; 13(6): 475-83, 1998.
Article in English | MEDLINE | ID: mdl-10543463

ABSTRACT

The purpose of the study was to investigate a possible myocardial sparing effect by dynamic cardiomyoplasty. We directly measured cardiac work and myocardial oxygen consumption after dynamic cardiomyopathy in dogs with adriamycin-induced cardiomyopathy. Ten dogs with cardiomyopathy induced by 4 weekly intracoronary infusions of adriamycin were studied. Five dogs underwent right latissimus dorsi cardiomyoplasty with progressive myostimulation, and five served as controls. Right heart and coronary sinus catheterizations were performed at 0, 10, and 15 weeks. Four and two dogs, respectively, the cardiomyoplasty and the control group, survived until 15 weeks. Cardiac work was not different between the control and the cardiomyoplasty groups (p = 0.42). Myocardial oxygen consumption was less in the cardiomyoplasty group (185.70 +/- 37.22; 165.75 +/- 25.86; 161.40 +/- 54.14 J/min at 0, 10, and 15 weeks, respectively) compared to the control group (147.80 +/- 70.99; 275.00 +/- 103.24; 263.50 +/- 52.75 J/min at 0, 10, and 15 weeks, respectively, p = 0.019). Mechanical cardiac efficiency was not meaningfully different between the cardiomyoplasty group (16.08% +/- 5.39%; 20.51% +/- 5.89%; 20.67% +/- 11.98% at 0, 10, and 15 weeks, respectively) compared to the control group (15.29% +/- 8.06%; 9.40% +/- 1.22%; 13.40% +/- 2.29% at 0, 10, and 15 weeks, respectively, p = 0.093). Acute changes of the cardiosynchronization ratio (2:1, 1:1, OFF) did not affect myocardial oxygen consumption or cardiac work within the cardiomyoplasty group. Dynamic cardiomyoplasty reduced myocardial oxygen consumption in dogs with adriamycin-induced cardiomyopathy.


Subject(s)
Cardiomyopathy, Dilated/surgery , Cardiomyoplasty/methods , Myocardium/metabolism , Oxygen Consumption , Animals , Cardiac Catheterization/methods , Cardiomyopathy, Dilated/chemically induced , Cardiomyopathy, Dilated/metabolism , Dogs , Doxorubicin , Echocardiography
17.
J Am Vet Med Assoc ; 211(5): 569-72, 1997 Sep 01.
Article in English | MEDLINE | ID: mdl-9290821

ABSTRACT

Partial atrioventricular (AV) septal defects consist of an ostium primum defect and malformation of the septal cusp of the mitral valve. A partial AV septal defect was diagnosed by means of echo-cardiography in 2 dogs. Transatrial septal blood flow was high enough in both dogs to warrant surgical correction. Defects were repaired through right fifth intercostal thoracotomies, with the aid of cardiopulmonary bypass. An incision was made in the right atrium to expose the AV septal defect, and the mitral valve was inspected through the septal defect. The cleft in the septal cusp of the mitral valve was repaired with mattress sutures of 6-0 polypropylene. The septal defect was closed with autogenous pericardium harvested from the right aspect of the pericardial sac. Both dogs survived surgery and were alive 15 and 42 months, respectively, after surgery, however, 1 dog developed progressive mitral regurgitation after surgery. Partial AV septal defects can be successfully repaired in dogs. Long-term prognosis probably depends on the adequacy of the mitral valve repair.


Subject(s)
Dog Diseases/diagnosis , Dog Diseases/surgery , Heart Septal Defects, Atrial/veterinary , Heart Septal Defects, Ventricular/veterinary , Mitral Valve/abnormalities , Animals , Dog Diseases/diagnostic imaging , Dogs , Echocardiography/methods , Echocardiography/veterinary , Heart Septal Defects, Atrial/diagnosis , Heart Septal Defects, Atrial/surgery , Heart Septal Defects, Ventricular/diagnosis , Heart Septal Defects, Ventricular/surgery , Male , Mitral Valve/surgery , Treatment Outcome
18.
Am J Respir Cell Mol Biol ; 16(4): 366-71, 1997 Apr.
Article in English | MEDLINE | ID: mdl-9115746

ABSTRACT

Thickening of peripheral pulmonary arteries (PA) in the pulmonary hypertensive neonate has been well described morphologically, but less is known regarding the role of cell proliferation in either the normal or hypertensive neonatal PA. Thus we studied DNA synthetic indices in the tunica media and tunica adventitia of four different sizes/generations of PA in normoxic calves (n = 15) and calves exposed to hypobaric hypoxia (n = 15) during the first 14 days of life. DNA synthetic indices were determined by incorporation of the thymidine analogue bromodeoxyuridine (BrdU). Hemodynamic studies confirmed a steady decline in PA pressure in normal neonatal calves during the first 2 wk of life and progressive pulmonary hypertension in the hypoxic group. Lungs were perfusion-fixed and pulmonary arteries were evaluated for BrdU incorporation by immunohistochemistry. DNA synthetic indices (BrdU-labeled cells/1,000 cells) in the tunica media from normoxic calves were highest between 4 and 7 days postpartum and decreased to their lowest levels by day 14. The highest indices were observed in smaller generations of PA in the normoxic newborn. Adventitial cells exhibited the same general pattern of BrdU incorporation except that the postpartum peak occurred earlier, at 1 to 4 days. Exposure to hypoxia significantly increased (P = 0.001) DNA synthetic indices in both the tunica media and adventitia. The highest DNA synthetic indices were observed in smaller-generation vessels. These findings indicate that the fraction of cells traversing the S phase (i.e., actively replicating in the cell cycle) in the normal neonatal pulmonary vasculature during transition are initially high compared to reported rates in hilar PA from adult rats, but then decrease by 14 days after birth. Further, exposure to hypoxia during transition dramatically increases and prolongs pulmonary vascular cell proliferation. We conclude that structural remodeling in the hypertensive neonatal PA is due partly to increased cell proliferation in the tunica media and adventitia.


Subject(s)
Bromodeoxyuridine/metabolism , Hypoxia/metabolism , Pulmonary Artery/metabolism , Animals , Animals, Newborn , Cattle , Cell Division , Hypoxia/pathology , Immunohistochemistry , Male , Pulmonary Artery/pathology
19.
J Am Vet Med Assoc ; 209(7): 1255-61, 1996 Oct 01.
Article in English | MEDLINE | ID: mdl-8837645

ABSTRACT

OBJECTIVE: To describe the surgical technique for open resection of congenital subvalvular aortic stenosis in dogs and to determine outcome of dogs undergoing the procedure. DESIGN: Uncontrolled clinical trial. ANIMALS: 17 dogs with congenital discrete subvalvular aortic stenosis. PROCEDURE: Dogs were placed on cardiopulmonary bypass by catheterizing the femoral artery and both vena cavae. The aorta was cross clamped, and cold cardioplegia solution was administered. The aortic root then was opened with a curvilinear incision. A subvalvular discrete fibrous ring was resected in all dogs. Septal myectomy was performed simultaneously on 11 dogs. RESULTS: 15 of 17 dogs survived the operation and were discharged from the hospital. Mean +/- SD maximal instantaneous aortic systolic pressure gradient measured by means of Doppler echocardiography was significantly reduced from 119 +/- 42 mm of Hg before surgery to 41 +/- 10 mm of Hg 12 months after surgery. Despite substantial reduction in the systolic pressure gradient, 4 of 15 dogs died suddenly between 7 days and 30 months after surgery. Three of the 4 dogs that died suddenly had pressure gradients > or = 180 mm of Hg and ventricular tachycardia before surgery. Eleven dogs were still alive between 1 and 48 months after surgery. CLINICAL IMPLICATIONS: The procedure resulted in substantial reductions in systolic pressure gradients in dogs with severe congenital subvalvular aortic stenosis. However, some dogs with severe aortic stenosis died suddenly after surgery. Thus, this surgery should not be considered curative. Proof of a survival benefit in dogs undergoing this surgery will have to await longer term follow-up.


Subject(s)
Aortic Valve Stenosis/veterinary , Cardiopulmonary Bypass/veterinary , Dog Diseases/surgery , Animals , Aortic Valve Stenosis/congenital , Aortic Valve Stenosis/surgery , Blood Pressure , Death, Sudden, Cardiac/veterinary , Dog Diseases/congenital , Dogs , Echocardiography, Doppler/veterinary , Heart Septal Defects, Ventricular/surgery , Heart Septal Defects, Ventricular/veterinary , Postoperative Complications/veterinary , Treatment Outcome
20.
Circ Res ; 78(3): 388-94, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8593697

ABSTRACT

After vascular injury, quiescent adult smooth muscle cells (SMCs) revert to a more immature synthetic-state phenotype concomitant with the onset of cell replication. The relationship between SMC proliferation and the reexpression of genes characteristic of immature SMCs (eg,tropoelastin [TE]), on an individual cell basis, has not been determined. Using a combined bromodeoxyuridine (BrdU) immunocytochemistry-TE in situ hybridization technique, we determined the relationship between DNA synthesis and TE gene expression in the rat vascular wall during development of the aortic media (embryonic days 13 to 18), low but detectable levels of TE expression occurred equally in both replicating and nonreplicating SMCs. TE message levels dramatically increased in the late fetal and early postnatal periods (fetal day 19 to 1 month postpartum), after a precipitous drop in SMC replication, and then decreased to undetectable levels by postpartum day 60. After a balloon catheter injury in the adult, a developmental sequence of SMC replication followed by TE gene expression was reiterated in both the media and in the developing neointima. On an individual cell basis, adult SMCs replicating after injury expressed little or no TE message; detectable TE gene expression occurred only in nonreplicating SMCs. The most important implications of these data are that (1) adult SMCs replicating after injury appear to revert to a pre-elastogenic embryonic phenotype; (2) maximal TE expression occurs in SMCs only after the cessation of cell replication; and (3) in both the media and the neointima, adult SMCs responding to injury undergo temporarily sequential changes in phenotype reflective of SMC development.


Subject(s)
DNA/biosynthesis , Muscle, Smooth, Vascular/pathology , Tropoelastin/genetics , Animals , Aorta/growth & development , Aorta/metabolism , Aorta/pathology , Carotid Artery, Common/pathology , Cell Division , Embryonic and Fetal Development , Female , Immunohistochemistry , In Situ Hybridization , Male , Muscle Development , Muscle, Smooth, Vascular/growth & development , Muscle, Smooth, Vascular/metabolism , Pregnancy , RNA, Messenger/biosynthesis , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...